Intermountain Healthcare has been studying precision medicine extensively for the past several years and has developed its nationally leading Precision Cancer Genomics program. The program has been recognized for being able to conduct DNA testing that typically matches advanced cancer patients with medications that lengthen lifespan and improve quality of life, all at about the same cost of traditional cancer therapies.
At Intermountain Precision Genomics in-house laboratory, experts analyze the DNA and genetic makeup of a cancer patient's tumor, enabling detection of the individual genes with errors in a person's cancer to determine treatment options. The testing is proprietary to Intermountain Healthcare, but access to it is available to oncologists anywhere. The testing serves patients with late-stage cancer who have failed in a traditional treatment method.